Compare abrdn Income Credit Strategies Fund (ACP) vs Becton Dickinson and Co (BDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
abrdn Income Credit Strategies Fund vs Becton Dickinson and Co — how do they compare? abrdn Income Credit Strategies Fund trades at $5.11 (market cap $641.16M), while Becton Dickinson and Co trades at $180.75 (market cap $49.41B). The key difference: Becton Dickinson and Co is far larger — about 77.1× abrdn Income Credit Strategies Fund's market cap, and abrdn Income Credit Strategies Fund pays the higher dividend (18.2%). Which is the better fit depends on your goals.
| ACP | BDX | |
|---|---|---|
Market Cap | $641.16M | $49.41B |
Sector | Financials | Health |
52-Week High | $5.98 | $185.39 |
52-Week Low | $5.01 | $138.62 |
Dividend Yield | 18.2% | 2.32% |
Enterprise Value | — | $65.51B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end investment management company. Its primary goal is to generate high current income, with capital appreciation as a secondary objective. The fund mainly invests in debt and loan instruments from issuers across various industries and regions.
Read more on ACP →About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →
